Dermal Fillers Market is expected to reach US$ 7.58 billion by 2031

Biodegradable Segment to Lead Dermal Fillers Market Based on Product During 2023–2031

According to our new research study on “Dermal Fillers Market Forecast to 2031 – Global Analysis – by Product, Material, Application, End User, and Geography,” the market was valued at US$ 4.00 billion in 2023 and is projected to reach US$ 7.58 billion by 2031; it is expected to register a CAGR of 8.3% from 2023 to 2031. Key factors driving the market growth include the increasing preference for minimally invasive procedures and the rising attraction of consumers toward beauty and wellness. However, the high cost of dermal filler procedures hinders the market growth.

Countries such as India, South Korea, Thailand, Saudi Arabia, Malaysia, Mexico, and the UAE have emerged as the world's best medical tourism destinations. These countries are at the forefront of offering aesthetic services such as nose jobs, facelifts, lip jobs, liposuctions, and hair transplantation. Medical tourists from the US, Canada, and a few European countries travel to the above-mentioned countries for health and cosmetic treatments. According to the South Korean Ministry of Health and Welfare (MOHW), South Korea recorded a 70% increase in medical tourists from 2021 to 2022, with the number reaching ~248,000 in 2022 from 146,000 in 2021. As per the Society of Aesthetic Plastic Surgery, South Korea is among the countries performing the greatest number of plastic surgeries annually. Estimates by South Korean MOHW suggest that the country aims to attract ~700,000 international patients by 2027 to become a medical tourism hub in Asia. Therefore, with flourishing medical tourism, the demand for aesthetic procedures will likely surge in developing countries, bolstering the adoption of dermal fillers in the coming years. Low-cost procedures that do not compromise the treatment quality can primarily result in the growth of medical tourism and generate lucrative opportunities, which are among the factors contributing to the growing dermal fillers market size.

Dermal Fillers Market, by Region, 2023(%)

Dermal Fillers Market Analysis Based on Segmental Evaluation:

Based on product, the dermal fillers market is bifurcated into biodegradable and nonbiodegradable. In 2023, the biodegradable segment held a significant dermal fillers market share and is expected to register a higher CAGR in the market during 2023–2031. Biodegradable fillers are made from natural or synthetic materials broken down and metabolized by the body over time. The most common type of biodegradable filler is hyaluronic acid. Hyaluronic acid is naturally secreted in the skin to help retain moisture and volume. Other biodegradable fillers may comprise collagen, calcium hydroxyapatite, or poly-L-lactic acid. Key features of biodegradable dermal fillers include temporary, reversible, and natural-looking results. The body typically absorbs biodegradable fillers over time, so their effects are temporary. Depending on the specific filler used, they may last anywhere from several months to a couple of years. Also, in most cases, the effects of biodegradable fillers can be reversed using hyaluronidase, which breaks down the filler and allows it to be metabolized more quickly. Furthermore, biodegradable fillers provide natural-looking results, as they integrate well with the surrounding tissues and gradually dissipate as they are absorbed.

The longevity of biodegradable fillers depends on the type of dermal fillers used. For instance, dermal fillers such as human- and porcine-derived collagen and avian- and bacterial-derived hyaluronic acid last less than a year. Fillers such as calcium hydroxyapatite, dextran, poly-l-lactic acid, poly vinyl alcohol, and chitosan hydroxyethylmethacrylate cultured human fibroblasts are semi-permanent fillers with a longevity of 1–2 years. These products are safe and are easily approved by the Food and Drug Administration (FDA). For instance, JUVEDERM VOLUMA XC, offered by Allergan plc., is a sterile, biodegradable, non-pyrogenic, viscoelastic, clear, colorless, homogenized gel implant. In June 2020, the FDA approved JUVEDERM VOLUMA XC to enhance the chin region. Thus, the above-mentioned factors positively influence the overall growth of the dermal fillers market.

Based on material, the market is segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate, fat fillers, and others. In 2023, the hyaluronic acid segment held a significant dermal fillers market share and is expected to register the highest CAGR during the forecast period.

The scope of the dermal fillers market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. Asia Pacific is anticipated to register the fastest CAGR in the market from 2023 to 2031. Higher disposable income and high concern related to looks have created a favorable business environment for the dermal fillers market in APAC. Moreover, India is emerging as one of the growing markets for dermal fillers owing to the aging population, increasing income, and affordability, which is projected to support the Asia Pacific dermal fillers market during the forecast period. China and Japan are the major contributors to the growth of the market in the region due to the increasing popularity of dermal fillers and growing medical tourism. In China, dermal fillers are gaining significant traction in various public and private hospitals.

The burgeoning aesthetic industry, high prevalence of skin diseases, growing awareness of cosmetic procedures to enhance aesthetic appeal, and increasing demand for minimally invasive procedures (for skin rejuvenation and enhancement) propel the market growth in China. The Chinese economy is becoming an R&D-intensive economy, which is a major factor in the growth of the market in China. A few major factors boosting the market growth include increasing disposable income, coupled with the changing consumer habits of the Chinese population. Along with this, the presence of a significant middle-aged population is another prominent factor that drives the dermal fillers market growth in China. According to the Global Times (China), China established more than 5,150 new aesthetic institutions in 2020. The medical aesthetics market in the country reached 197.5 billion yuan (~US$ 30.5 billion), accounting for 17% of the global market. China is expected to become the world’s largest medical aesthetic market by reaching ~400 billion yuan (~US$ 55.5 billion) by 2025.  

A beauty culture that promotes radiant skin and youthfulness drives the demand for dermal filler treatments in Japan. Japanese consumers are exceptionally well-informed and inclined toward beauty and personal care products, and the popular items among the Japanese population include high-performance products, quick-acting skincare products, and crossover products. The consumers have the highest per capita expenditure in the region, which, in turn, boosts the market growth in the country. Unlike consumers in countries such as China and South Korea, Japanese consumers do not generally seek nonbiodegradable dermal filler products that offer semi-permanent or permanent results. This is due to the health risks and complications caused. Consumers in Japan tend to prefer hyaluronic acid products such as Belotero. Japanese women prefer a more natural and younger look, compared to the South Korea ‘plastic surgery obsessed’ counterparts, making biodegradable dermal fillers a rising trend among the Japanese and other Asian countries. Furthermore, elderly people in Japan value holistic approaches to skincare. Thus, there is an increasing preference for younger-looking skin and a growing geriatric population opting for dermal fillers, which, in turn, propels the dermal fillers market growth.

Moreover, the growing adoption of combination therapies is projected to bring new dermal fillers market trends in the coming years.

AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KGaA, Suneva Medical, Bioxis Pharmaceuticals, Bioplus Co. Ltd., Teoxane Laboratories, Bioha Laboratories, Prollenium Medical Technologies, and Sinclair Pharma Ltd are among the leading companies profiled in the dermal fillers market report.

Based on product, the dermal fillers market is bifurcated into biodegradable and nonbiodegradable. In terms of material, the market is classified into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate, fat fillers, and others. By application, the market is categorized into facial line correction treatment, lip enhancement, facelift, scar treatment, and others. In terms of end user, the market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. Geographically, the dermal fillers market is categorized into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com